scispace - formally typeset
Search or ask a question

Showing papers by "Dennis Deapen published in 2006"


Journal ArticleDOI
TL;DR: First-time prevalence estimates for BRCA1/BRCA2 in breast cancer cases among understudied racial and age groups are provided and key predictors of mutation carrier status for both White and Black women and women of a wide age spectrum with breast cancer in the general population are shown.
Abstract: Although well studied in families at high-risk, the roles of mutations in the BRCA1 and BRCA2 genes are poorly understood in breast cancers in the general population, particularly in Black women and in age groups outside of the very young. We examined the prevalence and predictors of BRCA1 and BRCA2 mutations in 1,628 women with breast cancer and 674 women without breast cancer who participated in a multicenter population-based case-control study of Black and White women, 35 to 64 years of age. Among cases, 2.4% and 2.3% carried deleterious mutations in BRCA1 and BRCA2, respectively. BRCA1 mutations were significantly more common in White (2.9%) versus Black (1.4%) cases and in Jewish (10.2%) versus non-Jewish (2.0%) cases; BRCA2 mutations were slightly more frequent in Black (2.6%) versus White (2.1%) cases. Numerous familial and demographic factors were significantly associated with BRCA1 and, to a lesser extent, BRCA2 carrier status, when examined individually. In models considering all predictors together, early onset ages in cases and in relatives, family history of ovarian cancer, and Jewish ancestry remained strongly and significantly predictive of BRCA1 carrier status, whereas BRCA2 predictors were fewer and more modest in magnitude. Both the combinations of predictors and effect sizes varied across racial/ethnic and age groups. These results provide first-time prevalence estimates for BRCA1/BRCA2 in breast cancer cases among understudied racial and age groups and show key predictors of mutation carrier status for both White and Black women and women of a wide age spectrum with breast cancer in the general population.

340 citations


Journal ArticleDOI
TL;DR: Black and Hispanic women were less likely to be diagnosed with early-stage breast cancer than were White women, and the decreased likelihood of early detection among Hispanic women remained significant.
Abstract: Objectives. Previous research has generally found that racial/ethnic differences in breast cancer stage at diagnosis attenuate when measures of socioeconomic status are included in the analysis, although most previous research measured socioeconomic status at the contextual level. This study investigated the relation between race/ethnicity, individual socioeconomic status, and breast cancer stage at diagnosis. Methods.Women with stage 0 to III breast cancer were identified from populationbased data from the Surveillance, Epidemiology, and End Results tumor registries in the Detroit and Los Angeles metropolitan areas. These data were combined with data from a mailed survey in a sample of White, Black, and Hispanic women (n=1700). Logistic regression identified factors associated with early-stage diagnosis. Results. Black and Hispanic women were less likely to be diagnosed with earlystage breast cancer than were White women (P<.001). After control for study site, age, and individual socioeconomic factors, the odds of early detection were still significantly less for Hispanic women (odds ratio [OR]=0.45) and Black women (OR=0.72) than for White women. After control for the method of disease detection, the White/Black disparity attenuated to insignificance; the decreased likelihood of early detection among Hispanic women remained significant (OR=0.59). Conclusion. The way in which racial/ethnic minority status and socioeconomic characteristics produce disparities in women’s experiences with breast cancer deserves further research and policy attention.

228 citations


Journal ArticleDOI
TL;DR: There is a need for fundamental changes in patient education to ensure that women are able to make informed decisions about their breast cancer treatment, including an increase in the use of decision aids and the speed at which treatment decisions are made.

153 citations


Journal ArticleDOI
01 Mar 2006-Cancer
TL;DR: Hispanics comprise almost one‐third of the population of California, are the most rapidly increasing racial/ethnic group in the state, and represent almost one-third of all Hispanics in the U.S.
Abstract: BACKGROUND Hispanics comprise almost one-third of the population of California, are the most rapidly increasing racial/ethnic group in the state, and represent almost one-third of all Hispanics in the U.S. California has among the highest rates of melanoma in the world, yet little is known about trends in melanoma in its Hispanic population. METHODS Trends in invasive and in situ melanoma incidence data and melanoma mortality data, between 1988 and 2001, from the California Cancer Registry were analyzed. Trends in the Hispanic population were compared with those in the non-Hispanic white population. Time trends in tumors of differing thicknesses and histology were assessed. RESULTS There was a statistically significant 1.8% per year increase in incidence of invasive melanomas among Hispanic males and a similar but nonstatistically significant increase in invasive melanoma among Hispanic females between 1988 and 2001. Among Hispanic males and females tumors thicker than 1.5 mm at presentation increased at 11.6% per year (95% confidence interval [CI], 8.1, 15.2) and 8.9% per year (95% CI, 4.7, 13.3), respectively. CONCLUSION Rates of invasive melanoma have increased markedly among Hispanics in California since 1988. In contrast to trends in the non-Hispanic white population, increases in melanoma in Hispanics have been confined to thicker tumors, whose prognosis is poor. We recommend that efforts be undertaken immediately to target both primary and secondary melanoma prevention messages to Hispanic communities. Cancer 2006. © 2006 American Cancer Society.

112 citations


Journal ArticleDOI
TL;DR: Variations in the associations between known breast cancer risk factors and risk of different breast cancer histologies were observed, and some insight is provided into the different etiologies of various histologic subtypes of breast cancer.
Abstract: Background: Important differences in the contributions of certain exposures to the risks of ductal versus lobular breast carcinomas have been observed, but few studies have evaluated the relationships between established breast cancer risk factors and other histologic types. Methods: Information on family history of cancer and reproductive, hormonal, anthropometric, and lifestyle characteristics were collected in a multicenter population-based case-control study consisting of 3,463 ductal, 274 lobular, 261 ductal-lobular, 91 medullary, 77 tubular, 70 comedo, and 61 mucinous invasive breast carcinoma cases (ages 35-64 years, newly diagnosed 1994-1998) and 4,682 controls. Associations between each of these histologic types and various exposures were evaluated using polytomous regression. Results: Heterogeneity in the risks of different histologic types of breast cancer was observed for three exposures: menopausal hormone use, body mass index (BMI), and alcohol consumption. Specifically, current use of unopposed estrogen was associated with a reduced risk of ductal carcinoma and increased risk of comedocarcinoma, and current use of estrogen and progestin was associated with elevated risks of ductal-lobular and tubular carcinomas. Among postmenopausal women, BMI was only inversely related to risk of ductal-lobular carcinoma, and alcohol use was only positively related to risk of lobular carcinoma. Conclusions: Variations in the associations between known breast cancer risk factors and risk of different breast cancer histologies were observed. Although these findings require confirmation, and the analyses of some histologic groups were limited by small sample sizes, they provide some insight into the different etiologies of various histologic subtypes of breast cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(5):946–54)

96 citations


Journal ArticleDOI
TL;DR: The findings suggest that similar patients may get different treatment depending on their surgeon, and broader dissemination of guidelines coupled with increasing patient access to consultations before definitive surgery may reduce between-surgeon variation.
Abstract: Background Determinants of between-surgeon variation in breast cancer treatment utilization are not well understood. Objectives The objectives of this study were to evaluate variation in receipt of surgical treatment (ie, mastectomy or breast-conserving surgery with or without radiation) for women with stage I, II, or III breast cancer and receipt of breast reconstruction attributable to surgeons, and to assess factors associated with this between-surgeon variation. Methods We surveyed all attending surgeons (n = 456) of a population-based sample of patients with breast cancer diagnosed in Detroit and Los Angeles during 2002 (n = 1844). Our analytic dataset linked data from 1477 patients with that of 311 surgeons. We used random-effects modeling to account for the multilevel dataset and evaluated 2 outcomes: 1) primary surgical treatment (mastectomy vs. BCS); and 2) receipt of reconstruction before being surveyed (yes vs. no). Independent variables included patient-related factors (clinical and demographic), surgeon-related factors (breast procedure volume, practice setting, and demographics), surgeon treatment recommendation, and referral propensity. Results Surgeons explain some variation in use of both mastectomy and reconstruction (9.9% and 26%, respectively). Patient clinical factors and surgeon volume together explain approximately one-third of the between-surgeon variation in mastectomy. Patient factors and surgeon demographics explain approximately 60% of between-surgeon variation in reconstruction, and surgeon referral propensity explains an additional 15%. Conclusion Our findings suggest that similar patients may get different treatment depending on their surgeon. Broader dissemination of guidelines coupled with increasing patient access to consultations before definitive surgery may reduce between-surgeon variation. Contributing factors such as patient-physician communication should be explored.

81 citations


Journal ArticleDOI
TL;DR: Age-related racial differences in breast cancer risk in women with a family history of breast cancer are found and risk estimates are updated for white and AA women for clinical use.
Abstract: Purpose Family history is a well-recognized risk factor for breast cancer. Familial aggregation and segregation analyses have estimated breast cancer risk based on family history primarily for white women; such information is limited for African American (AA) women. The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women. Methods We used family cancer history from 2,676 white and 1,525 AA women with breast cancer (probands) in the population-based National Institute of Child Health and Human Development's Women's Contraceptive and Reproductive Experiences (CARE) Study to estimate age-specific breast cancer risks in their first degree adult female relatives. Cumulative hazard curves were calculated for relatives of all probands using Cox proportional hazards models, and were stratified by the proband's race and age at diagnosis and number of relatives affected. Results Breast cancer risks for white and AA women with a fam...

20 citations


Journal ArticleDOI
TL;DR: A proper balance between measures to protect privacy and the ability to guard and improve public health requires careful consideration and development of appropriate policies, regulations and use of technology.
Abstract: Rapid advances in informatics and communication technologies are greatly expanding the capacity for information capture and transportation. While these tools can be used for great good, they also offer new opportunities for those who seek to obtain and use information for improper purposes. While issues related to identity theft for financial gain garner the most attention, protection of privacy in public health endeavors such as cancer surveillance is also a significant concern. Some efforts to protect health-related information have had unintended consequences detrimental to health research and public health practice. Achieving a proper balance between measures to protect privacy and the ability to guard and improve public health requires careful consideration and development of appropriate policies, regulations and use of technology.

19 citations


Journal ArticleDOI
TL;DR: Determining patients' desired role in decision making may be as important as achieving a shared decision for evaluating perceived quality of care in surgical breast cancer treatment.
Abstract: 6031 Background: The choice of surgical breast cancer treatment represents an opportunity for shared decision making (SDM), since both mastectomy and breast conserving surgery are viable options. Y...

1 citations